ClinicalTrials.gov
ClinicalTrials.gov Menu

Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00625469
Recruitment Status : Withdrawn (competing studies did not allow enrollment)
First Posted : February 28, 2008
Last Update Posted : March 6, 2018
Sponsor:
Collaborator:
Actelion
Information provided by (Responsible Party):
Rajan Saggar, University of California, Los Angeles

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : June 2009
  Estimated Study Completion Date : December 2009